Catalyst Wire Dossier Catalyst Wire Dossier

NiCord

omidubicel · Gamida Cell Ltd
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NiCord, covering 2019-02-26 to 2022-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS [Phase 3]

See pricing